Iron: Clinical Trials

17 trials of Iron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 2 unknown, 2 withdrawn, 1 terminated. 17 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 12, Unknown 2, Withdrawn 2, Terminated 1
Phase 12Completed 2
Phase 32Completed 2

Follow Iron: new trials by email Literature Review of Iron trials Research Report on Iron

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.
intravenous iron, oral iron - Postpartum Anaemia
Phase 1 / Phase 2CompletedFederal Teaching Hospital Abakaliki2902018-09-132025-08-08
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
Epoetin Alfa and Iron, Iron - Cyanotic Congenital Heart Disease, Anemia
Phase 2TerminatedUniversity of California, San Diego42016-11-012021-12-02
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
Iron - Prevention of Anemia
Phase 1 / Phase 2CompletedHippocration General Hospital502016-11-012020-07-29
Effect of Iron and Folic Acid on Skin Fungal Pattern in Patients With Arsenicosis
Placebo, Iron 150 mg and Folic acid 0.5 mg - Chronic Arsenic Poisoning
Phase 2CompletedBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh422016-06-012017-07-13
Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
Ferumoxytol intravenous, Ferrous sulfate - Restless Legs Syndrome, Iron Deficiency Anemia
Phase 2CompletedAuerbach Hematology Oncology Associates P C1002014-08-012024-01-30
Safe and Efficacious Iron for Children in Kenya
Low-dose iron as NaFeEDTA, Conventional dose iron as ferrous salt, Placebo - Anaemia
Phase 2 / Phase 3CompletedLondon School of Hygiene and Tropical Medicine3382014-06-012015-04-10
Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
PT20, Placebo - Hyperphosphataemia
Phase 2CompletedPhosphate Therapeutics1532014-05-072018-01-16
Fermented Iron-rich Supplement in Reducing Anemia
supplement containing 60 mg iron sulfate, iron rich food supplement (60 mg iron), iron rich food supplement (10 mg iron) - Iron Deficiency Anemia
Phase 2UnknownUniversity of Ghana1202014-03-012014-01-16
The Safety and Effectiveness of Jobelyn in Pre-operative Management of Anaemia in Gynaecological Patients
Jobelyn, Ferrous Sulphate + Folic Acid - Anemia
Phase 2CompletedLagos State University732012-12-012016-05-18
Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease
Growth Hormone, Nutraceutical Combination, Exclusion Diet - Crohn's Disease
Phase 2WithdrawnColumbia University2012-03-012015-04-13
Impact of Vitamin B12 Supplementation With Iron and Folic Acid on Adolescent Girls
Iron, Folic acid and Cyanocobalamin, Iron and Folic Acid - Anaemia
Phase 2UnknownIndian Council of Medical Research3602012-01-012012-02-28
Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment
Roxadustat, Oral Iron, IV Iron - Dialysis, Anemia
Phase 2CompletedKyntra Bio602011-07-212021-10-01
Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
Soluble Ferric Pyrophosphate in liquid bicarbonate, Placebo: Conventional liquid bicarbonate, Erythrocyte Stimulating Agent (ESA) - End Stage Renal Disease
Phase 2CompletedRockwell Medical Technologies, Inc.1082011-01-012018-10-01
Study of Phosphate Levels in Patients With Chronic Kidney Disease
1.25 g PA21 (250 mg iron), 5.0 g PA21 (1,000 mg iron), 7.5 g PA21 (1,500 mg iron) - Chronic Kidney Disease
Phase 2CompletedVifor Pharma1542008-12-012014-04-01
Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Epoetin Alfa plus Iron - Anemia
Phase 2WithdrawnUniversity of Louisville2007-05-012018-03-05
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Thalidomide, Iron - Obscure Gastrointestinal Bleeding, Angiodysplasia
Phase 2CompletedShanghai Jiao Tong University School of Medicine552004-11-012015-12-17
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Sodium Ferric Gluconate Complex, Oral Iron - Iron Deficiency Anemia
Phase 2 / Phase 3CompletedWatson Pharmaceuticals1462003-12-012013-07-08

Conditions studied

Anemia (7)  ·  Anemia, Iron-Deficiency (3)  ·  Kidney Failure, Chronic (2)  ·  Angiodysplasia (1)  ·  Crohn Disease (1)  ·  Cyanosis (1)  ·  Gastric Antral Vascular Ectasia (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Heart Defects, Congenital (1)  ·  Hyperphosphatemia (1)  ·  Inflammatory Bowel Diseases (1)  ·  Renal Insufficiency, Chronic (1)  ·  Restless Legs Syndrome (1)  ·  Vascular Malformations (1)

Sponsors

Auerbach Hematology Oncology Associates P C (1)  ·  Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Columbia University (1)  ·  Federal Teaching Hospital Abakaliki (1)  ·  Hippocration General Hospital (1)  ·  Indian Council of Medical Research (1)  ·  Kyntra Bio (1)  ·  Lagos State University (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Phosphate Therapeutics (1)  ·  Rockwell Medical Technologies, Inc. (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  University of California, San Diego (1)  ·  University of Ghana (1)  ·  University of Louisville (1)

Countries

United States (8)  ·  Russia (3)  ·  Bulgaria (2)  ·  Croatia (2)  ·  India (2)  ·  Nigeria (2)  ·  Poland (2)  ·  Bangladesh (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Kenya (1)  ·  Mexico (1)  ·  Puerto Rico (1)

Top investigators

Adetokunbo O Tayo, M.D. (1)  ·  Alfred E Slonim, MD (1)  ·  David K Werho, MD (1)  ·  Dr. Anupa Siddhu, Ph.D (1)  ·  Dr. Gurdayal S Toteja, Ph.D (1)  ·  Dr. Naval K Vikram, M.D. (1)  ·  Dr. Neena Bhatia, Ph.D (1)  ·  Gary Hoel, RPh, PhD (1)  ·  Geoff Block, MD (1)  ·  Goetz H Kloecker, MD (1)  ·  Hans Verhoef, PhD (1)  ·  Manju Reddy, PhD (1)  ·  Michael Auerbach, MD (1)  ·  Mir Misbahuddin, PhD (1)

Results publications

PMID 40576086, PMID 26154926, PMID 28449690, PMID 28770094, PMID 29391008, PMID 32651955, PMID 36005278